March 27, 2018
RegMed Investors’ (RMi) closing bell; hammered and an all but a clean sweep of the sector
March 22, 2018
RegMed Investors’ (RMi) closing bell; the sell-off returns
March 22, 2018
RegMed Investors’ (RMi) pre-open: historical data can’t always determine current events
March 15, 2018
RegMed Investors’ (RMi) pre-open: the Ides of March is here
March 10, 2018
Regenerative Medicine Earnings Scorecard - Q4 and FY17 - to date
March 6, 2018
Fibrocell (FCSC) FDA Allowance of IND for FCX-013 for the treatment of Moderate to Severe Localized Scleroderma
March 4, 2018
RegMed Investors’ (RMi) wrapping-up January and February while determining March’s strength …
March 1, 2018
RegMed Investors’ (RMi) closing bell; the sector got spooked by the market sell-off
February 22, 2018
RegMed Investors’ (RMi) pre-open: was the upside a trading “tourist” event?
February 7, 2018
RegMed Investors’ (RMi) closing bell; recovery with stronger gains while volatility is still high
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.